Share Prices & Company Research

Stockbroking

Hikma Pharmaceuticals

Current Price 1908.50p Bid 1908.50p Ask 1910.00p Change 1.61%
Last Updated: 13/11/2019 15:03. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Hikma Pharmaceuticals plc principal activities are the development, manufacture, and marketing of a broad range of branded and non-branded generic pharmaceuticals products across the US, the Middle East and North Africa (MENA) and Europe. Hikma is also a leading licensing partner in MENA.

Financial Highlights Year Ended 31/12/2018

Turnover
£2,070.00m
Operating Profit
£371.00m
Dividend Yield
1.66
Dividend Per Share
38.00
Dividend Cover
2.93
P/E Ratio
16.06

Key Personnel

Sigurdur Oli Olafsson
Chief Executive Officer
Said Samih Darwazah
Executive Chairman
Mazen Samih Darwazah
Executive Vice Chairman
Mary Regina Henderson
Non-Executive Director
Dr Pamela Josephine Kirby
Non-Executive Director
Robert Mark Pickering
Non-Executive Director
Cynthia Louise Schwalm
Non-Executive Director
Dr Jochen Gann
Non-Executive Director
John Julius Castellani
Non-Executive Director
Patrick Noel Butler
Non-Executive Director
Ali Mohammed Al-Husry
Non-Executive Director

Stock Details

EPIC
HIK
ISIN
GB00B0LCW083
Shares in Issue
242,311,898
Market cap
£4,553.04m

Analyst Views (4)

Strong Buy
 
25.00%
Buy
 
0.00%
Hold
 
75.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
1909.25p
Bid Price
1908.50p
Ask Price
1910.00p
Volume
201795
Change Today
30.25p
% Change Today
1.61%
Open
1895.00p
Previous Close
1879.00p
Intraday High
1911.00p
Intraday Low
1870.50p
52 Week High
2212.00p
52 Week Low
1491.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Hikma Pharmaceuticals Intra-day Chart

Hikma Pharmaceuticals News

News in this section is provided by AJ Bell

Hikma Pharmaceuticals says revenue from generics business to be at top end of range 07 Nov 2019 | 07:16 Hikma Pharmaceuticals launches pre-filled syringes in US 17 Sep 2019 | 09:16 Director Deals - Hikma Pharmaceuticals PLC (HIK) 06 Sep 2019 | 15:30 Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC 20 Aug 2019 | 08:40 Cocktail of risks sours FTSE 100 performance 09 Aug 2019 | 16:45 FTSE gathers some ground after GDP-inspired fall for the pound 09 Aug 2019 | 12:08 Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC 09 Aug 2019 | 09:30 Hikma Pharmaceuticals acquires manufacturing platform, two pipeline products from Insys Therapeutics 09 Aug 2019 | 09:14 UK stocks open down 0.2% as Italian coalition government teeters 09 Aug 2019 | 09:02 Hikma Pharmaceuticals upgrades outlook amid 'strong' sales in H1 09 Aug 2019 | 07:19 Hikma Pharmaceuticals inks agreement to sell Gedeon Richter's antipsychotic in MENA region 25 Jul 2019 | 09:01 Hikma Pharmaceuticals enters into supply agreement with Civica 23 Jul 2019 | 13:09 Hikma Pharmaceuticals on track to meet expectations amid 'good' start to year 17 May 2019 | 07:44 Hikma Pharmaceuticals launches injectable antibiotic treatment in US 01 May 2019 | 13:28 Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC 21 Mar 2019 | 10:00 Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC 19 Mar 2019 | 10:10 Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC 19 Mar 2019 | 10:00 Director Deals - Hikma Pharmaceuticals PLC (HIK) 18 Mar 2019 | 15:45 Director Deals - Hikma Pharmaceuticals PLC (HIK) 18 Mar 2019 | 15:40 Director Deals - Hikma Pharmaceuticals PLC (HIK) 15 Mar 2019 | 11:35 Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLC 14 Mar 2019 | 12:10 Director Deals - Hikma Pharmaceuticals PLC (HIK) 14 Mar 2019 | 11:45 Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC 14 Mar 2019 | 09:10 FTSE steady amid swings in sterling ahead of no deal vote 13 Mar 2019 | 15:34 Director Deals - Hikma Pharmaceuticals PLC (HIK) 13 Mar 2019 | 15:30 Director Deals - Hikma Pharmaceuticals PLC (HIK) 13 Mar 2019 | 15:30 UK stocks open flat as investors brace for no-deal Brexit vote 13 Mar 2019 | 08:58 Hikma Pharmaceuticals swings to profit led by ongoing growth in injectables business 13 Mar 2019 | 08:03 Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC 12 Mar 2019 | 09:00 Hikma Pharmaceuticals US unit launches injectable cancer treatment 29 Jan 2019 | 13:07

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
870.0
828.0
Intangible Assets & Goodwill
766.0
785.0
Investments & Other Non-Current Assets
193.0
201.0
Total Non-Current Assets
1,829.0
1,814.0
Inventory
528.0
488.0
Trade & Receivables
731.0
707.0
Cash & Receivables
276.0
227.0
Other Current Assets & Assets Held for Resale
133.0
152.0
Total Assets
3,497.0
3,388.0

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
893.0
797.0
Long Term Liabilities
907.0
1,063.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1,800.0
1,860.0

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
1,697.0
1,528.0

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
40.0
40.0
Minority Interests
12.0
14.0
Retained Earnings
1,580.0
0.0
Share Premium Account
282.0
282.0
Other Equity
-217.0
1,192.0
Total Equity
1,697.0
1,528.0

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
430.0
443.0
Cashflow Before Financing
334.0
292.0
Increase / Decrease in Cash
56.0
72.0

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
2,070.0
1,936.0
Cost of Sales
1,020.0
969.0
Gross Profit
1,050.0
967.0
Operating Profit
371.0
-747.0
Pre-Tax Profit
293.0
-738.0
Profit / Loss for the Year
285.0
-839.0

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H1 Dividend
22 Aug 2019
23 Sep 2019
H2 Dividend
04 Apr 2019
22 May 2019
H1 Dividend
23 Aug 2018
21 Sep 2018
H2 Dividend
05 Apr 2018
24 May 2018
H1 Dividend
24 Aug 2017
22 Sep 2017
H2 Dividend
06 Apr 2017
25 May 2017
H1 Dividend
01 Sep 2016
30 Sep 2016
H2 Dividend
07 Apr 2016
19 May 2016
H1 Dividend
27 Aug 2015
25 Sep 2015
H2 Dividend
16 Apr 2015
21 May 2015
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.